Even if TLD were to be announced, there will be a spin that they cherry picked, slanted the statistics, statisticians are paid by the company, what would expect? Anyway, price won’t go beyond $5!
Patience will pay off and disregard the empty cans that will be beating furiously the closer we get to TLD.
Good Post. WS knows most retail investors dont have the stomach to handle long delays and related missed-timelines often associated with investing in pre-revenue biotech. They know this game well. This waiting period is more about human phycology than it is about TLD.
While I think NWBO Management has not run the ship on the straight and narrow at times, I do think they will bring DCVAX to the finish line.